ZYRTEC HIVES RELIEF OTC
Generic Name and Formulations:
Cetirizine HCl 10mg; tabs.
McNeil Consumer Healthcare
Indications for ZYRTEC HIVES RELIEF:
Itching due to urticaria.
Adults and Children:
<6yrs: not recommended. ≥6yrs: initially 5–10mg once daily. ≥65yrs: use syrup: 5mg once daily. Hepatic or renal impairment: individualize.
Hives Relief: not used for prevention or as a substitute for epinephrine. Hepatic or renal dysfunction. Pregnancy. Nursing mothers: not recommended.
Potentiates CNS depression with alcohol, other CNS depressants.
Drowsiness, somnolence, fatigue, dry mouth, pharyngitis. Children: headache, pharyngitis, GI upset/pain, cough, somnolence, diarrhea, epistaxis, bronchospasm, fatigue, irritability, insomnia.
Tabs—5, 14, 30, 45, 75; Liquid gels—12, 25, 40; Chew tabs 5mg—5, 10mg—12, 24; Hives Relief tabs—14; Syrup—4oz
Clinical Pain Advisor Articles
- Abuse-Deterrent Opioid Formulations: Barriers to Broader Use
- Women Frequently Prescribed High Doses of Opioids After Vaginal Delivery
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Medical Cannabis Legalization Associated With Reduced Schedule III Opioid Prescriptions
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- Opioid Use Disorder Prevalence at Delivery on the Rise in the US, According to CDC
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Pharmacologically Induced Headache Accompanied by Dilated Cephalic Vessels
- IV Lidocaine May Be Safe, Efficacious for Pediatric Status Migraine
- Gray Matter Changes in Migraine Associated With Clinical Characteristics